Ra Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Ra Pharmaceuticals Ownership

Who owns Ra Pharmaceuticals?

Ra Pharmaceuticals is owned by UCB S.A.. It was acquired on October 10, 2019.

Was Ra Pharmaceuticals formerly PE-backed?

Yes. Ra Pharmaceuticals was formerly owned by 1 private investor.

Ra Pharmaceuticals Business Overview

Where is Ra Pharmaceuticals headquartered?

Ra Pharmaceuticals is headquartered in Cambridge, Massachusetts.

What is Ra Pharmaceuticals’ revenue?

Ra Pharmaceuticals disclosed revenue of 3M USD for 2018 and 5M USD for 2016.

How many employees does Ra Pharmaceuticals have?

Ra Pharmaceuticals has 72 employees.

What sector is Ra Pharmaceuticals in?

Ra Pharmaceuticals is a life science company.

When was Ra Pharmaceuticals founded?

Ra Pharmaceuticals was founded in 2008.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.

Ra Pharmaceuticals, Inc.

87 Cambridge Park Drive,
Cambridge, Massachusetts 02140
United States,
(617) 401-4060
www.rapharma.com

Ra Pharmaceuticals, Inc. is a biotechnology company that combines novel insights into innate immunity with leadership in macrocycle technology to transform the lives of patients with life-threatening disorders. Ra Pharmaceuticals was formed in 2008 and is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.